Absolent published preliminary Q1 numbers on April 23rd due to weak performance in the latter part o...
Redeye is encouraged by the results from the LION study, demonstrating penetration of laquinimod int...
Q1 adj. EBITA EUR +0.9m, strong result given seasonality We raise '25e-'27e EBITA by EUR 3-2m Capita...
Redeye updates its forecast following Modelon’s Q1 2025 report, where results came roughly in line w...
Redeye initiates coverage of Indutrade, one of the largest Swedish niche acquirers, which has succes...
Förväntat svag tillväxt men starkare e-handel än väntat Bruttoresultatet minskade med 5,4 procent ti...
Positive organic growth in Q1 and acceleration Q2-Q4e Estimates cut on divestments; underlying more ...
Last week, CI Games published its year-end report, which showed sales relatively in line with our es...
Redeye provides a brief comment on Scandinavian ChemoTech's order intake for April, announced early ...
Redeye comments on OssDsign’s CEO change, announced earlier this week.
Redeye sees a couple of bright spots in the Q1 report, but the uncertain business climate still make...
Redeye retains its positive view of Momentum Group following a stable Q1 report.
Redeye provides a comment following yesterday’s announcement from Catella regarding the divestment o...
Redeye strengthens its positive view of Formpipe following the Q1 report.
Føroya Banki reported a solid Q1, as profit before loan losses landed at DKK 56m, DKK 3m (7%) better...